Indivior Pharmaceuticals (INDV) Operating Expenses (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Operating Expenses of $139.0 million for Q1 2026, down 10.9% year-over-year from $156.0 million in Q1 2025, and down 34.12% quarter-over-quarter from $211.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Operating Expenses (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Operating Expenses history runs 3 years deep, the most recent figure standing at $139.0 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 10.9% year-over-year to $139.0 million; the TTM figure through Mar 2026 stood at $715.0 million (down 20.99% YoY), while the FY2025 annual figure was $732.0 million, down 20.35% from the prior year.
- Operating Expenses for Q1 2026 stood at $139.0 million, down from $211.0 million in the prior quarter.
- The five-year high for Operating Expenses was $338.0 million in Q2 2024, with the low at $139.0 million in Q1 2026.
- The 3-year median for Operating Expenses is $187.0 million (2025), against an average of $199.0 million.
- Peak annual rise in Operating Expenses reached 2.93% in 2025, while the deepest fall reached 47.34% in 2025.
- Indivior Pharmaceuticals' Operating Expenses stood at $205.0 million in 2024, then climbed by 2.93% to $211.0 million in 2025, then sank by 34.12% to $139.0 million in 2026.
- Business Quant data shows INDV's Operating Expenses at $139.0 million in Q1 2026, $211.0 million in Q4 2025, and $187.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn | 134.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 134.00 Mn |
| Mar 31, 2026 | 139.00 Mn |
| Dec 31, 2025 | 211.00 Mn |
| Sep 30, 2025 | 187.00 Mn |
| Jun 30, 2025 | 178.00 Mn |
| Mar 31, 2025 | 156.00 Mn |
| Dec 31, 2024 | 205.00 Mn |
| Sep 30, 2024 | 206.00 Mn |
| Jun 30, 2024 | 338.00 Mn |
| Mar 31, 2024 | 171.00 Mn |